bluebird bio Opens Manufacturing, Research Facility in Durham, N.C.
Bluebird bio has officially opened a facility in…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Ninlaro Maintenance Therapy Prolongs and Boosts Treatment Benefits in Myeloma Patients, Study Says
Maintenance therapy with Ninlaro (ixazomib) can prolong…
ChemioCare Developing New Lenalidomide Skin Patch
Aiming to improve lenalidomide‘s safety and efficacy, ChemioCare…
MMRF Launches Fund to Invest in Innovative Firms for Multiple Myeloma Research
The Multiple Myeloma Research Foundation (MMRF) has launched…
Cellectis Plans Clinical Trial to Test Donor-derived CAR T-cell Therapy, Possible Multiple Myeloma Treatment
Cellectis announced plans to open a Phase 1 clinical…
Trial to Evaluate Daratumumab/Revlimid as Maintenance for Some Multiple Myeloma Patients
Janssen Biotech is planning a new Phase 3 clinical…
